Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2026
Fractional Exhaled Nitric Oxide for Diagnosing Eosinophilic Chronic Rhinosinusitis: A Systematic Review and Meta-analysis.
СтатьяСистематический обзорМетаанализНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lee Jae Yoon, Al Ali Manal, Kim Soo Whan, Kim Sung Won
Аннотация
OBJECTIVE: The current gold standard for diagnosing eosinophilic chronic rhinosinusitis (ECRS) is tissue biopsy, but due to its invasive nature, there is a need for clinical diagnosis in outpatient settings or presurgical evaluations.
DATA SOURCES: PubMed, Embase, Cochrane Central Register of Controlled Trials, Web of Science, and Scopus up to July 2024.
REVIEW METHODS: Compared the fractional exhaled nitric oxide (FeNO) levels between ECRS and non-ECRS patients. The risk of bias across studies was evaluated utilizing the ROBINS-I tool.
RESULTS: Twelve studies comprising 1159 participants were included. The pooled mean difference in FeNO levels between ECRS and non-ECRS patients was 32.21 ppb (95% CI: [19.36, 45.06], P < .001). The diagnostic odds ratio for FeNO in identifying ECRS was 8.78 (95% CI: [5.70, 13.51], P < .001).
CONCLUSION: FeNO levels are significantly elevated in ECRS patients compared to non-ECRS patients. The high diagnostic odds ratio suggests that FeNO has potential as a noninvasive diagnostic tool for ECRS.
DATA SOURCES: PubMed, Embase, Cochrane Central Register of Controlled Trials, Web of Science, and Scopus up to July 2024.
REVIEW METHODS: Compared the fractional exhaled nitric oxide (FeNO) levels between ECRS and non-ECRS patients. The risk of bias across studies was evaluated utilizing the ROBINS-I tool.
RESULTS: Twelve studies comprising 1159 participants were included. The pooled mean difference in FeNO levels between ECRS and non-ECRS patients was 32.21 ppb (95% CI: [19.36, 45.06], P < .001). The diagnostic odds ratio for FeNO in identifying ECRS was 8.78 (95% CI: [5.70, 13.51], P < .001).
CONCLUSION: FeNO levels are significantly elevated in ECRS patients compared to non-ECRS patients. The high diagnostic odds ratio suggests that FeNO has potential as a noninvasive diagnostic tool for ECRS.